MapLight Therapeutics to Showcase Innovations at Investor Events - Maplight Therapeutics To Participate In Upcoming Investor Conferences
March 3, 2026
New Center for Endometriosis Surgery Opens in Washington, DC - Endometriosis Surgery And Multidisciplinary GYN Care Center Opens In DC
Washington Endometriosis and Complex Surgery opens a new center in DC, enhancing care for endometriosis patients during Awareness Month.
March 2, 2026
NFL's Mental Health Crisis: Addressing Growing Challenges - Rising Mental Health Challenges In Pro Football Expose Urgent Need For Support
Rondale Moore's tragic death highlights mental health challenges in the NFL, revealing an urgent need for improved support for players.
March 1, 2026
Empowering Women: MonmouthFlow Hosts International Women's Day Event - International Women's Day Celebration At Monmouthflow, March 8
MonmouthFlow Yoga + Wellness and NSN celebrate International Women's Day on March 8 with workshops, yoga, and community support for women.
February 27, 2026
Dr. Casey Means Advocates for Public Health at Senate Hearing - WATCH: Dr. Casey Means Testifies At Senate Confirmation Hearing For Surgeon General
Dr. Casey Means testifies at her Senate confirmation hearing, advocating for preventive care and health equity as essential to the Surgeon General role.
February 26, 2026
New Research Challenges Vaccine Safety Claims by Robert F. Kennedy Jr. - Recent Studies Challenge Kennedy's Claims About Vaccines, Tylenol And Antidepressants
Studies challenge Robert F. Kennedy Jr.'s claims about vaccines, Tylenol, and antidepressants, raising concerns over misinformation and public health.
February 25, 2026
Surge in Seniors Experiencing Overlooked Breathing Issues - ER Doctors: More Seniors Are Coming In With This Overlooked Breathing Symptom
Emergency rooms are seeing a rise in seniors with shortness of breath, prompting doctors to highlight the need for awareness and proactive health management.
February 22, 2026
Long-Term TREMFYA® Data Show Promising Results in Ulcerative Colitis - TREMFYA® (Guselkumab) Long-Term Data Show Sustained Clinical And Endoscopic Remission In Ulcerative Colitis Through 3 Years
TREMFYA® shows promising long-term results in ulcerative colitis, with over 80% in clinical remission after three years. Significant findings from QUASAR study.
February 22, 2026